The weight-management semaglutide product is Wegovy, whose indications cover cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight, long-term weight reduction in adults and pediatric patients aged 12 and older with obesity and in adults with overweight plus at least one weight-related comorbid condition, and noncirrhotic MASH with moderate to advanced fibrosis
Its one of the most powerful endogenous antioxidants in the body that is required to maintain health and well-being, along with immune system performance
Always discuss your conception timeline with your OB/GYN before starting or stopping any medication
He rated his overall experience with Noom as a 5 out of 5
Ahmann AJ, Capehorn M, Charpentier G et al (2018) Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial
Two people can both fit the same FDA-approved indication and still reach different decisions, because eligibility answers whether a door is open, not whether walking through it serves your situation